We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Beta-blockers did not improve clinical outcomes after ...
Hosted on MSN
Beta-blockers are no longer needed in post-infarction patients with normal heart function, study confirms
A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...
Beta blockers have long been widely prescribed for patients with heart issues, but two new studies this week question the benefit of the therapies in certain patients with strong heart function. One ...
In a recent study published in The New England Journal of Medicine, researchers conducted the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE-AMI) ...
Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...
A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...
Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily, new study suggests. Half of all patients discharged from hospital after a heart attack ...
Share on Pinterest Experts say beta-blockers are essential medications for a number of heart-related conditions. Shikhar Bhattarai/Stocksy Beta-blockers are used to treat heart problems and high blood ...
A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide clear benefits for heart attack patients ...
β-blockers may increase depression risk in heart attack survivors with normal heart function, questioning their necessity for this group. The REDUCE-AMI trial found long-term β-blocker use linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results